arrow_back Back to App

Improved Prescription Drug Information: Your Right to Know

This new act mandates standardized, easy-to-understand paper information to be included with all prescription drugs. The goal is to enhance patient safety, reduce adverse drug events, and lower healthcare costs associated with hospital visits. Citizens will gain comprehensive knowledge about their medications, their effects, and potential side effects.
Key points
Mandatory, standardized paper leaflets: Every prescription drug will come with an easy-to-understand leaflet containing key information.
Detailed drug information: Leaflets will include drug name, indications, proper use, contraindications, side effects, interactions, and manufacturer contact details.
Increased safety and savings: Better medication knowledge aims to prevent errors, reduce hospital visits, and improve treatment outcomes.
Accessibility for all: Information will be provided in paper format, crucial for those without internet access or electronic devices.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_5133
Sponsor: Rep. Bentz, Cliff [R-OR-2]
Process start date: 2025-09-04
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Patients’ Right to Know Their Medication Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_5133.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-04.

What are the main provisions?

Key points include:

  • Mandatory, standardized paper leaflets: Every prescription drug will come with an easy-to-understand leaflet containing key information.
  • Detailed drug information: Leaflets will include drug name, indications, proper use, contraindications, side effects, interactions, and manufacturer contact details.
  • Increased safety and savings: Better medication knowledge aims to prevent errors, reduce hospital visits, and improve treatment outcomes.
  • Accessibility for all: Information will be provided in paper format, crucial for those without internet access or electronic devices.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Bentz, Cliff [R-OR-2].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health